We investigated the presence of factors in human milkthat inhibit Invasion of pathogenic bacteria. The efl'ect of human milk fat globule membrane (HMFGM) components on adhesion of cloned S-fimbriated Escherichia coli to human buccal epithelial cells was analyzed. S fimbriae are a common feature of E. coli strains causing sepsis and meningitis in newborns and are bound to epithelia via sialyl-(a-2-3)galactoside structures. Human milk fat globules (HMFG) could be agglutinated by the above-mentioned bacteria. Agglutination could be inhibited by fetuin, human glycophorin, and a 1 -acid glycoprotein. In addition, pretreatment of HMFG with Jlibrio cholerae neuraminidase markedly reduced bacterium-induced agglutinations, indicating the involvement of neuraminic acid-containing glycoproteins. In contrast, Iipid droplets of infant formula or artificiallipid emulsions (Intralipid) could not be agglutinated. HMFG were present in stools of breast-fed neonates as shown by indirect immunofluorescence staining with a monoclonal antibody directed against carbohydrate residues present on HMFGM. These HMFG could be agglutinated by bacteria. HMFG inhibited E. coli adhesion to buccal epithelial cells. To further characterize relevant E. coli binding structures, HMFGM components w~re separated by gel chromatography. The mucin fraction showed the most pronounced inhibitory efrect on adhesion of S-fimbriated E. coli to human buccal epithelial cells. Our data soggest that HMFG inhibit bacterial adhesion in the entire intestine and thereby may provide protection against bacterial infection.
Human milk provides protection against different types of infections (9) . This protective function is based on a complex immunologic system. The importance of immunoglobulins, predominantly secretory immunoglobulin A and other factors such as Iysozyme, lactoferrin, the lactoperoxidase system, and cellular components (macrophages, lymphocytes) has been assessed. Further protective properties can be ascribed to nonimmunoglobulin components such as glycolipids, glycoproteins, and free oligosaccharides that are capable of inhibiting bacterial adhesion to epithelia, thus preventing bacterial infection at the stage of bacterial colonization (1, 2, 14, 20) .
Adhesion of bacteria to target cells is usually mediated by well-defined glycoproteins on bacterial fimbriae (5, 21, 27) . S-fimbriated Escherichia coli organisms used in our studies are of major importance in newborns as pathogens causing sepsis and meningitis (23) . Adhesins, lectinlike molecules of S fimbriae, recognize receptor structures present in a variety of membrane glycoproteins expressing NeuAc a-2-3 residues (17, 28, 33) .
Milk fat in human milk is concentrated in globules with diameters of 1 to 10 IJ.ffi (29, 35) . The membrane surrounding the Iipid core is derived from the apical plasma membrane of mammary epithelial cells by apocrine secretion (11, 12) . High-molecular-mass glycoproteins with a high content of 0-glycosidic-linked carbohydrates (termed mucins) are a major constituent of these membranes (7, 13, 41) . As these human milk fat globule membranes (HMFGM) are of epithe-lial origin, we expected them to express carbohydrate structures that might serve as receptor analogs for certain pathogenic bacteria. For porcine milk fat globule membranes, binding of porcine enteropathogenic K88-positive E. coli and inhibition of guinea pig hemagglutination by K88-positive E. coli has been described previously (3, 4) . Therefore, we addressed two major questions: (i) can human milk fat globules (HMFG) inhibit binding of S-fimbriated E. coli to epithelial cells, and (ii) what are the relevant membrane components mediating inhibition of bacterial adhesion?
MATERIALS AND MEmODS
Bacteria. Adhesion experiments were carried out with E. coli HB101 with the recombinant plasmid (pANN 801-4) which encodes S fimbriae (17) . In controls, E. coli HB101 organisms without plasmid and therefore without S fimbriae were used. Only in a few preliminary experiments, because of the instability of S fimbria expression in vitro, strain IH 3084 (kindly provided by T. Korhonen, University of Helsinki, Helsinki, Finland), which was isolated from a patient with neonatal meningitis and which also carries S fimbriae, was used. Bacteria were grown on NB agar (Difco Laboratories, Detroit, Mich.) supplemented with 0.1% glucose and tetracycline (30 IJ.g/ml). After an 18-h incubation period at 37°C, bacteria were harvested with ice-cold 20 mM sodium borate buffer, pH 9.0, and washed twice with the same buffer. Following adjustment to 10 10 bacteria per ml, 1 ml of the suspension was Iabelied with 100 ...,g of ftuorescein isothiocyanate (FITC) (Sigma Chemical Co., St. Louis, MO.) with constant shaking for 30 min at 23°C. To remove excess FITC, the reaction mixture was Jayered on top of 4 ml of phosphate-buffered saline (PBS) containing 6% (wt/vol) bovine serum albumin (BSA) and centrifuged (15 min, 1,500 x g). The pellet containing Iabeiied bacteria was washed once or twice with PBS ( containing 0.1% BSA and 0.5% methyl-a-o-mannoside ), pH 7 .4, until the supernatant was clear (32) .
Isolation of buccal epithelial cells. Buccal epithelial cells were obtained from healthy adult nonsmokers by scraping buccal mucosa with a spoon-shaped spatula several times. Cells were washed off the spatula with PBS, washed three more times, and were microscopically adjusted to 10 5 cells per ml.
Binding of bacteria to buccal epithelial cells and preincubation ofbacteria with inhibitors. Bacteria in buffer (2 x 10 8 /ml) or the bacterium-inhibitor mixture was added to 250 ._.,t of epithelial cell suspension (ratio of cells to bacteria, 1:1,000) and incubated for 60 min in a shaking ice bath. Epithelial cells were washed three tim es with PBS ( centrifugation for 5 min at 4°C and 120 x g) before microscopic evaluation.
For inhibition studies, 125 ..._t of the bacterial suspension (2 x lOH bacteria per ml) was incubated with 125 ._.,1 of one of the following inhibitors for 15 min in an ice bath: human glycophorin (HGP) (1 mglml), a 1 -acid glycoprotein (10 mg/ ml), fetuin (5 mglml), HMFG, HMFGM fractions (1 mglml), asialo-HGP (1 and 8 mglml), and NeuAc (1 to 20 mglml, adjusted to pH 7.4). By using the viable count technique, it was shown that inhibitors did not influence the bacteria's viability. All chemieals were obtained from Sigma.
In order to better define receptor structure, 2 x 10 5 epithelial cells were treated with Vibrio cholerae neuraminidase (1 U/ml; Behring, Marburg, Germany) for 1 h at 37°C and washed twice with PBS. The number of bacteria binding to the cell surface was analyzed by ftuorescence microscopy. Fifty epithelial cells were analyzed for each experiment. All experiments were done in duplicate. Isolation of milk fat globules from human colostrum and stools of breast-fed infants. Fifty milliliters of fresh milk collected on the fourth day of Iactation was used for agglutination experiments. The milk was centrifuged at 1,000 x g at room temp~rature for 30 min to obtain cream. The cream was washed four times in 10 volumes of sucrose-PBS (0.25 M sucrose, to which was added 10% PBS, pH 7.4). HMFG in sucrose-PBS were used at a concentration 20 times higher than the concentration resulting in an optical density of 1.8 at 605 nm. Freshly obtained cow's milk was treated in an identical manner. For control experiments, an adapted infant formula (Pre-Aptamil; Milupa) and Intralipid 20% (Kabi Vitrum, Stockholm, Sweden) were used, the latter as a control for artificial phospholipid membranes. Stools of five breast-fed and five formula-fed infants (day 4) as weil as the ileostomy secretions of a 10-day-old breast-fed infant with intestinal atresia were mixed with 4 volumes of sucrose-PBS and centrifuged in the same manner as milk. The Iipid layer on top was taken off and washed six times with sucrose-PBS. Major particles were removed mechanically between centrifugation steps.
Demonstration of HMFG in stools of breast-fed infants. Fifty microliters of the washed Iipid fraction isolated from stools of breast-fed and formula-fed newborns was added to a 1:50,000 dilution of ascitic fluid containing monoclonal antibody directed against HMFGM, 115 G 3 (kindly provided by J. Hilkens, University of Amsterdam, Amsterdam, The Netherlands). The antibody recognizes the carbohydrate structure Galß-1-
[Fuca-1-3]-GlcNAcß (Lewis 3 and Lewisx sequence) (15) . The mixture of antibody and Iipid fraction was incubated for 10 min in an ice bath with gentle shaking. Cross-reaction has been shown for mucins in various body ftuids. Excess antibody was removed by washing before 20 .... 1 of a phycoerythrin-labelled goat anti-mouse antibody (Southern Biotechnology Associates, Birmingham, Ala.) diluted 1:10 in PBS was added. Following another incubation period of 10 min at 4°C in the dark, 200 ._.,t of sucrose-PBS was added for ftuorescence microscopy. Nonspecific mouse immunoglobulin (Sigma) was used in a control experiment instead of the monoclonal antibody.
Preparation of HMFGM. Freshly secreted human breast milk (first 14 days of lactation) was obtained from volunteers, pooled, and defatted by centrifugation at 3,000 x g for 1 h at 4°C. The cream was washed several times in 5 volumes of 0.01 M Tris HCI, pH 7 .2, by centrifugation under the same conditions. Washed cream from appfoximately 3 Iiters of human milk was suspended in a total volume of 500 ml of 0.01 M Tris HCI, pH 7.2, and kept in the cold (4°C) for 1 h. The suspension was then allowed to reach room temperature while it was shaken on a Iabaratory shaker until butter formed. The process of membrane release was completed by incubation of the mixture at 40°C for 30 min. The membranes were recovered as a yellow pellet after centrifugation at 35,000 x g (30 min) and washed twice with water prior to freeze-drying.
Agglutination of HMFG and HMFGM by bacteria. Agglutinations of HMFG from colostrum and stools and Iipid droplets from infant formula and Intralipid suspended as described above were analyzed after mixture of 1 drop of suspension with 1 drop of bacterial (E. co/i HB101 [pANN 801-4) and E. coli IH 3084) Suspension (5 x 10 9 /ml) on a glass slide at 4°C and room temperature with gentle shaking. Sonicated HMFGM were treated in an analogaus manner. In control experiments, bacteria without plasmid were used.
In inhibition experiments, 20 ...,1 of bacterial suspension was mixed with 20 ._.,t of putative inhibitor at different concentrations for 15 min at 4°C. NeuAc served as a monovalent control, and asialo-HGP served as a polyvalent control. Agglutination intensity was .read macroscopically and microscopically. To determine the roJe of NeuAc in HMFG residues responsible for bacterial binding, 40 ._.,t of HMFG was incubated with 1 ml of V. cholerae neuraminidase (1 U/ml) at 37°C, washed, and then added to the bacteria.
Isolation and immunochemical characterization of HMFGM mucin. Solubilization of the membrane proteins and fractionation according to their sizes were performed as described by Shimizu and Yamauchi (41) . Fractions HMFG-A to HMFG-D (see Fig. 2 ) were dialyzed against waterat 4°C, freeze-dried, and delipidated by extraction with cold methanol-chloroform (1/2, vol/vol).
HMFG-A was immunochemically identified as the polymorphic epithelial mucin-containing fraction after chemical deglycosylation with triftuoromethanesulfonic acid according to the method of Hakimuddin and Bahl (18) . Binding of monoclonal antibody SM-3 defining the peptide sequence Pro-Asp-Thr-Arg-Pro (6) was analyzed in a double-sandwich solid-phase enzyme immunoassay by using anti-mouse immunoglobulin (Z 259; Dako, Hamburg, Germany) and antialkaline phosphatase-alkaline phosphatase complex detection.
Isolation and purification of S fimbriae. S fimbriae were isolated essentially according to the procedure described by Salit and Gotschlich (37) The puritY of the preparation was eonfirrned by sodium dodecyl sulfate (SDS)-polyaerylamide gel eleetrophoresis and examination by eleetron mieroseopy.
Electrophoresis and binding of fimbriae to transblots. Glyeoprotein samples (1 mg preineubated ·in 100 J.Ll of sample buffer eontaining 0.3% SDS and 3% 2-mereaptoethanol for 10 min at 90°C) were separated on polyaerylamide gels (7 .5% or 3 to 13%) in the presenee of SOS (0.1%) at 40 mA. Gels were fixed and stained with Coomassie blue or periodie acid Sehiff's (PAS) reagent. Eleetroblotting onto nitroeellulose (0.45 J.Lm) was perforrned at 200 mA in Tris (25 mM)-glycine (192 mM)-methanol (20% ).
The nitroeellulose sheets were immersed in PBS, pH 7.2, eontaining 5% (wt/vol) BSA to bloek residual surfaee aetivity and overlaid with a solution of Ieetin peroxidase eonjugate diluted in 0.5% BSA-PBS (5 to 10 J,Lg/ml). As leetins, peroxidase-labelled Ieetins from Triticum vulgaris (WGA) and from Arachis hypogeae (PNA) were used. After ineubation for 1 h at room temperature and three sueeessive washing steps (0.5% BSA-PBS), the membranes were developed in PBS-methanol (17% [vol/vol]) containing 1-ehloro-4-naphthol (0.055%) and hydrogen peroxide (0.008% ). Maximum staining was obtained after 30 min in the dark. For binding of purified fimbriae, membranes were overlaid for 17 h with fimbriae suspended in PBS (125 J,Lg of protein per ml) or with fimbriae and HGP (1 mglml) at 4°C.
For immunostaining, membranes were ineubated for 1 h at 4°C with monoclonal antibody A 21356 Al (1:1,000), whieh recognizes S fimbriae (28) (kindly provided by K. Jann). Alkaline phosphatase-conjugated anti-mouse immunoglobulin (1:1,000) (Dako) was added for 30 min at room temperature and washed four times with PBS. Membranes were developed with 5-bromo-4-ehloro-3-indoxyl-phosphate (Na 2 salt) and Nitro Blue Tetrazolium ehloride (Serva, Heidelberg, Germany) for 15 min at 37°C.
RESULTS
Adhesion of S-fimbriated E. co/i to human buccal cells. Fluoreseenee mieroseopy of bueeal epithelial eells after ineubation with FITC-labelled S-fimbriated E. coli showed that 75 to 95% of epithelial eells from 10 different donors had bound baeteria. On average, 1,103 (±293) baeteria had bound to 50 eells. Charaeteristies of binding of the clinieal isolate IH 3084 to bueeal epithelial eells did not differ from those for the cloned strain HB101 (pANN 801-4) (data not shown). The abilities of human glyeophorin, fetuin, and a 1 -acid glyeoprotein to inhibit binding were markedly differ- (Table 1) . lf inhibitionwas less than 50%, individual values are given. NeuAe as a monovalent eontrol showed no inhibition; asialo-HGP as a polyvalent eontrol substanee was slightly able to inhibit binding. Pretreatment of epithelial eells with neuraminidase markedly redueed the number of binding bacteria to 27% of the eontrol, indicating the relevanee of NeuAc for binding of S fimbriae.
Agglutination of HMFG and HMFGM by bacteria. HMFG isolated from eolostrum were agglutinated by S-fimbriated E. coli HB101 (pANN 801-4) and IH 3084 after 10 min, as shown macroscopically and microscopically ( data not shown). HB101 without plasmid failed to agglutinate HMFG. Raising the temperature from 4°C to room temperature markedly aeeelerated the reaetion. This agglutination was probably due to speeifie interaction of bacteria with HMFGM beeause isolated membranes could also be aggregated (data not shown).
By using FITC-labelled monoclonal antibody (115 G 3) direeted against HMFGM (15) , undigested HMFG eould be demonstrated in both normal stools of breast-fed infants and intestinal fluid from one breast-fed infant with ileostomy. In contrast, stools of formula-fed infants were devoid of HMFG (Fig. 1a and b ) .
Nonspecific mouse immunoglobulin G did not react with HMFG. Globules isolated from stools could still be agglutinated by bacteria. Agglutination was not altered in slightly acidic conditions (stool of breast-fed infants, pH 5). In contrast, Iipid droplets isolated from adapted infant formula or Intralipid showed no reactions with bacteria either macroscopically or microscopically. Milk fat globules isolated from fresh cow's milk reacted, but the agglutination was weaker compared with that of HMFG.
Pretreatment of HMFG with neuraminidase almost completely abrogated agglutinability. Agglutination could be inhibited with concentrations of inhibitors identical to those used in the buccal epithelial cell binding assay. Inhibition by all effective inhibitorswas dose dependent from 0.15 to 20 mg/ml. (41) (Fig. 2) . The different fractions (HMFG-A to HMFG-D) obtained from column chromatography had extensively been characterized previously by Shimizu and Yamauchi (HMFG-A to HMFG-D corresponding to fractions F1 to F4 in their study) (41) .
Patterns of SDS-polyacrylamide gel electrophoresis obtained from HMFG and their Chromatographie subfractions are shown in Fig. 3 . Staining with Coomassie blue revealed a series of 10 major bands, most of which were PAS-reactive glycoproteins. The prominent mucin band at the top of the gel was found exclusively in fractions HMFG-A and -B, which appeared to be homogenaus on the basis of Coomassie blue and PAS staining. A Western blot (immunoblot) analysis of HMFGM glycoproteins by staining with WGA or PNA revealed strong binding activity by the HM FGM mucin for both lectins, while the membrane glycoproteins were stained only moderately or not at all (Fig. 3) . The presence of PNA-reactive Thomsen-Friedenreich antigen (Galß-1-3-GalNAc) on HMFGM mucin is a characteristic feature of this membrane component from lactating mammary epithelia (13) . A high sialic acid content of the HM-FGM mucin is indicated by its strong binding capacity for WGA on Western blots (41) . In addition, polymorphic epithelial mucin was identified in fraction HMFG-A by using monoclonal antibody SM-3 (data not shown).
HMFG-A and -B contain the mucins, but fraction A is regarded to be contaminated by other proteins responsible for the strong absorption at 280 nm. The pure mucin in fraction B does not absorb at 280 nm because of its Iack of aromatic amino acids. Accordingly, there is no relationship between antiadhesive effects and the protein profile registered at 280 nm.
HMFG and isolated fractions HMFG-A to -C were then functionally analyzed for the capacity to inhibit adhesion of our E. coli strain to buccal epithelial cells. The observed inhibition effects of HMFG (inhibition of adhesion, 46 to 55%) are probably due to a competition of HMFG versus buccal epithelial cells on a cellular Ievel. On the other band, in addition to reversible competition, irreversible entrapment of bacteria by HFMG agglutination is likely to contribute to the antiadhesive effect.
The strongest inhibitory effect of HMFGM fractions (55%) was located in mucin-containing fractions HMFG-A and HMFG-B ( Table 2 ). The efficiency of inhibition by fraction HMFG-A + B was comparable to that of HGP. Equal concentrations of HMFG-C sialoglycoproteins bad a markedly less pronounced inhibitory effect (18% inhibition).
Western blot analysis of HMFGM glycoproteins by immunostaining of bound S fimbriae revealed strong binding activity by high-molecular-mass glycoproteins of HMFGM (Fig. 4) . Binding of fimbriae was inhibited by the receptor analog HGP (Fig. 4) . The glycoproteins were positive on PAS and WGA staining and negative on Coomassie blue staining (data not shown). These high-molecular-mass glycoproteins should be regarded as mucins on the basis of several lines of evidence. The binding active components in Western blots are characterized by their molecular masses, which are higher than 200 kDa; a high carbohydrate content as demonstrated by staining with PAS and. WGA; and, finally, by cochromatography with polymorphic epithelial mucin from human skim milk (Fig. 4) .
DISCUSSION
In the present study, the ability of milk fat globules or membrane fractions to inhibit adhesion of S-fimbriated E.
coli to epithelial cells has been analyzed. The most meaningful test system to study antiadhesive properlies of milk fat c Sixty-three microliters of HMFG suspension corresponding to 3.8 I-L8 of Lowry protein_ globules present in stools is to use intestinal epithelia from newborns. Viable intestinal epithelia are difficult to obtain, and human intestinal cell lines as a putative alternative undergo morphological change with passage in tissue culture (10) .
Although adhesive properlies of a given bacteriaJ strain vary depending on the tissues used (42), we utilized buccal epithelial cells for two reasons: first, oral epithelia are an easily accessible part of the gastrointestinal tract, and, second, the oropharynx together with the intestine serves as a natural entry route for invasive pathogenic E. coli (16, 39) .
Adhesion of S-fimbriated E. coli to buccal epithelial cells is, like that of type I fimbriae carrying E. coli, age independent (8, 40) . Therefore, we used epithelial cells from adults as a model of bacterial adhesion.
The concept of bacterial adherence to milk fat globules has already been introduced in a variety of veterinary publications with reports of studies using E. coli K99 and K88 (3, 4, 25, 36) . Our studies show that these observations may be relevant for humans since pathogenic E. coli bind to HMFG and cause their agglutination. Agglutination was specifical~y inhibited by soluble receptor analogs (fetuin and HGP) or treatment of HMFG with neuraminidase. This indicates a majorroJe of Ne'-'Ac-containing glycoproteins as receptors for S-fimbriated bacteria. Lipid droplets derived from adapted infant formula or an intravenous fat emulsion are not surrounded by biomembranes and do not bind bacteria.
The role of mucins in the prevention of bacterial adhesion to epithelial tissues has been documented in recent studies (12, 26, 38) . Up to 200 carbohydrate chains are known to be FIG. 4 . Binding of isolated S fimbriae to immobilized glycoproteins on Western blots. Membraneproteins were separated on a 3 to 13% polyacrylamide gel in the presence of0.1% SOS. Western blots of HMFGM proteins (lanes 1 and 2) and mucin isolated from human skim milk (lane 3) were stained immunochemically after being overlaid with purified S fimbriae as described in Materials and Methods. Skim milk mucin, which was available from previous work (19) , was identified as the polymorphic epithelial mucin after chemical deglycosylation and immunochemical staining with monoclonal antibody SM-3. Lanes: 1, 0.5 mg of HMFG membranes overlaid with S fimbriae; 2, 0.5 mg of HMFG membranes overlaid with S fimbriae in the presence of HGP (1 mg/ml); 3, 100 ~g of mucin isolated from human skim milk, overlaid with S fimbriae. 0-glycosidically linked to the peptide core of a mucin monomer exhibiting a high degree of structural diversity. According to this particular property, mucins which are found in human secretions or in epithelial membranes are suitable candidates for representing organ-characteristic glycosylation and thus express a variety of receptor-analog structures for bacterial adhesins. Mucinsareregular constituents of human milk serum (19) and HMFGM (13) . The common structural unit of all acidic glycans on secretory milk mucins is the terminal disaccharide unit NeuAca-(2-3)-Galß, which has been demonstrated to form a receptor analog for S-fimbriated E. coli (22) .
The proteelive potential of membrane sialoglycoproteins and mucin on the milk fat globule against bacterial infections has not been demonstrated so far. But it is strongly suggested by the reported findings, in particular by the sialic acid-mediated binding of S-fimbriated E. coli to HMFGM and by the ability of HMFG and the isolated membrane mucins (fraction HMFG-A + B), to inhibit adhesion of these bacteria to buccal epithelial cells.
Recently, it has been reported that milk fat globule mucins in receptor binding assays have inhibitory activity (31) against human immunodeficiency virus and rotavirus (30) .
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HMFGM obviously express a !arge surface capable of binding S-fimbriated E. coli and thus decrease binding of bacteria to epithelial surfaces. As both buccal epithelia and gut epithelia are possible target cells for S-fimbriated E. coli, the resulting protective effect may be important for the entire intestine since HMFG isolated from ileostomy and stools are still agglutinable by bacteria. This is in accordance with published data indicating the excretion of up to 10% of the orally administered fat in stools of newborns due to relative exocrine pancreas insufficiency and low excretion of bile acids (24) .
On the other hand, it is unlikely that the whole amount of excreted fat is present in milk fat globules: conjugated bile salts at concentrations present in digests of term newborns and prematurely born infants are able to break up milk fat globules and release their membranes (34 ) .
The question of whether bacterial binding capacity of HMFG and HMFGM in digestsarerelevant in vivo in the intestine remains tobe answered. Moreover, the number of bacteria necessary to induce intestinal or extraintestinal infections in newborns is not known.
